NBS


Company Update (NASDAQ:NBS): NeoStem Inc Announces Proposed Public Offering of Common Stock

NeoStem Inc (NASDAQ:NBS) announced that it is commencing an underwritten public offering of its common stock. The Company intends to use the net proceeds …

H.C. Wainwright Maintains Buy on NeoStem Inc Following $17.7M Grant Announcement

In a research report issued Friday, H.C.

MLV Reiterates Buy on NeoStem Inc Following Expansion of Contract Agreement With Kite Pharma

MLV’s healthcare analyst Vernon Bernardino came out with an optimistic view on Neostem Inc (NASDAQ:NBS), after the company announced the expansion of its existing contract manufacturing services agreement …

MLV Remains Positive on NeoStem Inc Ahead of First Patient Randomization in Intus

MLV analyst Vernon Bernardino weighed in today with a few insights on NeoStem Inc (NASDAQ:NBS), as the company is expected to announce randomization of the first …

Maxim Comments On Neostem Following KOLs Presentation

In a research report sent to investors today, Maxim Group analyst Jason Kolbert maintained a Buy rating on Neostem (NASDAQ:NBS) with a price …

Maxim Group Remains Positive On Neostem After Reviewing Interviews From AHA Meeting

In a research report released today, Maxim Group analyst Jason Kolbert maintained a Buy rating on Neostem (NASDAQ:NBS) with a $15 price target, …

H.C. Wainwright Comments On Neostem Following AMR-001 Data Release

In a research report published Wednesday, H.C.

Maxim Remains Positive On Neostem Following PreSERVE AMI Phase 2 Results

Maxim Group analyst Jason Kolbert today joined the crowd, reiterating a Buy rating on Neostem (NASDAQ:NBS) with a price target of $15, following results from a trial …

MLV Reduces Neostem Price Target As NBS10 Shows A Mortality Benefit But May Require Further Study

In a research report issued today, MLV analyst Vernon Bernardino maintained a Buy rating on Neostem (NASDAQ:NBS) but reduced his price target to $14 …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts